We are live on ! Find out more
WGS icon

GeneDx Holdings

199 hedge funds and large institutions have $1.81B invested in GeneDx Holdings in 2024 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 70 increasing their positions, 32 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

361% more first-time investments, than exits

New positions opened: 83 | Existing positions closed: 18

126% more capital invested

Capital invested by funds: $799M → $1.81B (+$1.01B)

119% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 32

95% more call options, than puts

Call options by funds: $18.7M | Put options by funds: $9.61M

67% more funds holding in top 10

Funds holding in top 10: 610 (+4)

46% more funds holding

Funds holding: 136199 (+63)

15.75% more ownership

Funds ownership: 69.91%85.66% (+16%)

Holders
199
Holders Change
+63
Holders Change %
+46.32%
% of All Funds
2.62%
Holding in Top 10
10
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+66.67%
% of All Funds
0.13%
New
83
Increased
70
Reduced
32
Closed
18
Calls
$18.7M
Puts
$9.61M
Net Calls
+$9.13M
Net Calls Change
+$11.8M

WGS Hedge Fund Activity: Q4 2024 in Review

199 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q4 2024, worth a combined $1.81B — up 126% from $799M a quarter earlier.

Buyers outnumbered sellers: 83 funds opened new WGS positions and 18 closed out — a net gain of 65 holders — while 70 added to existing stakes and 32 trimmed.

The largest buyer was William Blair Investment Management, opening a new position worth an estimated $46.8M. The largest seller was Millennium Management, cutting an estimated $36M.

  • 199 institutional investors held GeneDx Holdings (WGS) as of Q4 2024, up from 136 in Q3 2024.
  • Funds reported $1.81B of GeneDx Holdings stock for Q4 2024, up 126% quarter-over-quarter.
  • 83 funds opened new GeneDx Holdings positions in Q4 2024 and 18 closed out, a net change of +65 holders.
  • The largest GeneDx Holdings buyer in Q4 2024 was William Blair Investment Management, an estimated $46.8M added.
  • The largest GeneDx Holdings seller in Q4 2024 was Millennium Management, an estimated $36M sold.

Based on aggregated 13F filings for Q4 2024.